D-0349-2019 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- December 26, 2018
- Initiation Date
- November 27, 2018
- Termination Date
- September 12, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,016 blister packs
Product Description
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40
Reason for Recall
Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.
Distribution Pattern
Nationwide
Code Information
Lot: 17180918, EXP June 2020